BioLineRx (BLRX) Other Non-Current Liabilities (2010 - 2026)
BioLineRx's Other Non-Current Liabilities came in at $2.42 million for the quarter ended Jun 30, 2026, down 44.5% from $4.36 million a year earlier but up 39.2% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Other Non-Current Liabilities was $2.17 million, up 28.6% from the prior year.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of -26.6% (years ended Dec 2020 to Dec 2025).
- Going back by year, Other Non-Current Liabilities was $1.69 million in the year ended Dec 31, 2024 (-85.8%), $11.93 million in the year ended Dec 31, 2023 (+164.6%), $4.51 million in the year ended Dec 31, 2022 (+142.5%) and $1.86 million in the year ended Dec 31, 2021 (-81.8%).
- The five-year range for quarterly Other Non-Current Liabilities is $186,000 (the quarter ended Jun 30, 2022) to $15.35 million (the quarter ended Jun 30, 2023).
- Year-over-year, Other Non-Current Liabilities increased in 1 of the last eight quarters, with an average decline of 38.8%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in the quarter ended Dec 31, 2023 (growth of 164.6%), and the weakest in the quarter ended Jun 30, 2022 (a decline of 96.1%).
- Business Quant data shows BLRX's Other Non-Current Liabilities at $1.74 million (quarter ended Mar 31, 2026), $2.17 million (quarter ended Dec 31, 2025) and $3.23 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.42 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Sep 30, 2024 | 4.37 Mn |
| Jun 30, 2024 | 5.09 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 11.93 Mn |
| Sep 30, 2023 | 15.29 Mn |
| Jun 30, 2023 | 15.35 Mn |
| Mar 31, 2023 | 7.55 Mn |
| Dec 31, 2022 | 4.51 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 186,000.00 |
| Mar 31, 2022 | 604,000.00 |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 4.01 Mn |
API Access
BioLineRx Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();